No Data
No Data
Jupiter Endovascular Exits Stealth With $21M in New Financing to Fund Pivotal Trial for Pulmonary Embolism
Neptune Medical Announces $97M Series D Financing and Spinout of Jupiter Endovascular
Shareholders Should Be Pleased With PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) Price
PROCEPT BioRobotics: A Strong Buy on Surging Sales and Upward Financial Trajectory
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
PROCEPT BioRobotics Corporation (PRCT) Q2 2024 Earnings Call Transcript
No Data